Two New Solutions from Hemex Health Empower More Clinicians and Health Workers to Test for Iron Deficiency Anaemia and Sickle Cell Disease

Q: How long will it take to read this news story?

The story "Two New Solutions from Hemex Health Empower More Clinicians and Health Workers to Test for Iron Deficiency Anaemia and Sickle Cell Disease" has 238 words across 8 sentences, which will take approximately 1 - 2 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "Two New Solutions from Hemex Health Empower More Clinicians and Health Workers to Test for Iron Deficiency Anaemia and Sickle Cell Disease" was covered 2 weeks ago by GlobeNewswire, a news publisher based in China.

Q: How trustworthy is 'GlobeNewswire' news outlet?

GlobeNewswire is a fully independent (privately-owned) news outlet established in 1998 that covers mostly technology news. The outlet is headquartered in China and publishes an average of 34 news stories per day. It's most recent story was published 11 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #23585306</li><li>URL: https://beamstart.com/news/two-new-solutions-from-hemex-17315892854348</li></ul>

GlobeNewswire 2w ago

Two New Solutions from Hemex Health Empower More Clinicians and Health Workers to Test for Iron Deficiency Anaemia and Sickle Cell Disease - GlobeNewswire

Quick Summary:

NAGPUR, India, Nov.14, 2024 (GLOBE NEWSWIRE) -- At the Haematocon 2024 conference in Nagpur, India, Hemex Health announced new product offerings for the Company’s Gazelle™ Diagnostic Device that will increase diagnostic accessibility for at-risk populations in challenging environments: A next generation Snap Cartridge, part of the Gazelle™ S-10B Hb Variant Test Multipack, will simplify sample preparation so that minimally trained health workers can perform the test for Hb Variants.

New Gazelle™ Hb Variant Test Multipack with the Snap Cartridge Offers Improved Usability for the Hb Variant Test The current Gazelle™ Hb Variant Test empowers frontline healthcare professionals to perform laboratory-quality testing of Hb Variants that can aid in the diagnosis of sickle cell disease (SCD) and beta thalassemia directly at the point of care.

It will ensure that people are able to receive timely care and health education.” "Point-of-care testing for ferritin is a transformative tool in our ability to diagnose and manage iron deficiency anaemia, sickle cell disease, thalassemia, and other haematologic and oncologic conditions worldwide, especially in low- and middle-income countries where the burden of these diseases is profound," said Dr.